
|Articles|October 1, 2013
- Applied Clinical Trials-10-01-2013
- Volume 22
- Issue 10
ACT Cover
S
Advertisement
Cover
Articles in this issue
about 12 years ago
Relationships Between Advocacy Groups and Pharmaabout 12 years ago
Does European Policy Still Have Room for Clinical Trials?about 12 years ago
Business and People October 2013about 12 years ago
EMA Unveils New Structure and Conflicts of Interestabout 12 years ago
Personalized Medicine, Data, and Meabout 12 years ago
Bridging the Disconnect in Pediatric Clinical Trial Recruitmentabout 12 years ago
The State of CRO and Sponsor Relationshipsabout 12 years ago
Smart Patients, Smarter Trialsabout 12 years ago
Sunshine Reporting Raises Concerns for Sponsors, InvestigatorsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
3
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
4
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
5